Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Bychkovsky BL"'
Autor:
Kotsopoulos J; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Lubinski J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Huzarski T; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Bychkovsky BL; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Moller P; Department of Tumour Biology, Institute of Cancer Research, The Norwegian Radium Hospital, 0379 Oslo, Norway., Kim RH; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Sinai Health System, Hospital for Sick Children, Ontario Institute for Cancer Research, Department of Medicine, University of Toronto, Canada., Tung N; Beth Israel Deaconess Medical Center, Boston, MA, USA., Eisen A; Toronto-Sunnybrook Regional Cancer Center, Toronto, ON, Canada., Foulkes W; McGill Program in Cancer Genetics, Department of Oncology, McGill University, Montreal, QC, Canada., Singer CF; Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Aeilts A; Division of Human Genetics, the Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, OH, USA., Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA., Bordeleau L; Department of Oncology, McMaster University, Hamilton, ON, Canada., Karlan B; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, CA, USA., Fruscio R; Clinic of Obstetrics and Gynecology, IRCCS Fondazione San Gerardo dei Tintori, Monza, Italy., Eng C; Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA., Olopade O; Department of Medicine and Human Genetics, University of Chicago, Chicago, IL, USA., Zakalik D; Cancer Genetics Program, Beaumont Hospital, Royal Oak, MI, USA., Couch F; Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Y Cajal TR; Familial Cancer Clinic, Medical Oncology, Hospital Santa Creu i Sant Pau, Barcelona, Spain., Sun P; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada., Gronwald J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Narod SA; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. Electronic address: steven.narod@wchospital.ca.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2024 Aug 21; Vol. 189, pp. 148-155. Date of Electronic Publication: 2024 Aug 21.
Autor:
Bychkovsky BL; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Myers S; Harvard Medical School, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA., Warren LEG; Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., De Placido P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Parsons HA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: heather_parsons@dfci.harvard.edu.
Publikováno v:
Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2024 Aug; Vol. 38 (4), pp. 831-849.
Autor:
Sandoval RL; Medical Oncology Center, Hospital Sírio-Libanês, Brasília, DF, Brazil.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA., Bottosso M; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.; Medical Oncology Department, Gustave Roussy Cancer Campus, INERM U981, Université Paris Saclay, France., Tianyu L; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Polidorio N; Breast Surgery Department, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bychkovsky BL; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA, USA., Verret B; Medical Oncology Department, Gustave Roussy Cancer Campus, INERM U981, Université Paris Saclay, France., Gennari A; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Cahill S; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Achatz MI; Medical Oncology Center, Hospital Sírio-Libanês, São Paulo, SP, Brazil., Caron O; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France., Imbert-Bouteille M; Oncology Department, Institut of Cancer of Montpellier, Montpellier, France., Noguès C; Cancer Risk Management Department, Clinical Oncogenetics, Institut Paoli-Calmettes, Marseille, France.; Aix Marseille Université, INSERM, IRD, SESSTIM, Marseille, France., Mawell KN; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Fortuno C; Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Spurdle AB; Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Tayob N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Andre F; Medical Oncology Department, Gustave Roussy Cancer Campus, INERM U981, Université Paris Saclay, France., Garber JE; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Aug 01; Vol. 116 (8), pp. 1246-1254.
Publikováno v:
Oncotarget [Oncotarget] 2024 Jul 10; Vol. 15, pp. 459-460. Date of Electronic Publication: 2024 Jul 10.
Autor:
Morganti S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Boston, MA, USA., Jin Q; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Vincuilla J; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA., Buehler R; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA., Ryan S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA., Stokes S; Broad Institute of MIT and Harvard, Boston, MA, USA., Parker T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA., Mittendorf EA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., King TA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Weiss A; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Division of Surgical Oncology, University of Rochester Medical Center, Rochester, NY, USA., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Bychkovsky BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; European Institute of Oncology IRCCS, Milan, Italy., Tayob N; Harvard Medical School, Boston, MA, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Garber JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Lynce F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. filipa_lynce@dfci.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. filipa_lynce@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. filipa_lynce@dfci.harvard.edu.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Apr 16; Vol. 10 (1), pp. 28. Date of Electronic Publication: 2024 Apr 16.
Autor:
Tarantino P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.; Department of Oncology and Hematology-Oncology, University of Milano, Milano, Italy. paolo_tarantino@dfci.harvard.edu., Gupta H; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Hughes ME; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Files J; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Strauss S; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kirkner G; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Feeney AM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Li Y; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Garrido-Castro AC; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Barroso-Sousa R; Dasa Institute for Education and Research (IEPD), Brasilia, Brazil.; Dasa Oncology/Hospital Brasilia, Brasilia, Brazil., Bychkovsky BL; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA., DiLascio S; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sholl L; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., MacConaill L; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lindeman N; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Weill Cornell Medicine, New York, NY, USA., Johnson BE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Meyerson M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Jeselsohn R; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Qiu X; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Li R; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Long H; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Winer EP; Yale Cancer Center, Yale School of Medicine, Smilow Cancer Hospital, New Haven, CT, USA., Dillon D; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Curigliano G; Division of Early Drug Development, European Institute of Oncology IRCCS, Milano, Italy., Cherniack AD; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Lin NU; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Publikováno v:
Nature communications [Nat Commun] 2023 Dec 14; Vol. 14 (1), pp. 8321. Date of Electronic Publication: 2023 Dec 14.
Autor:
Tarantino P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.; Department of Oncology and Hematology-Oncology, University of Milano, Milano, Italy. paolo_tarantino@dfci.harvard.edu., Gupta H; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Hughes ME; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Files J; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Strauss S; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kirkner G; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Feeney AM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Li Y; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Garrido-Castro AC; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Barroso-Sousa R; Dasa Institute for Education and Research (IEPD), Brasilia, Brazil.; Dasa Oncology/Hospital Brasilia, Brasilia, Brazil., Bychkovsky BL; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA., DiLascio S; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sholl L; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., MacConaill L; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lindeman N; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Weill Cornell Medicine, New York, NY, USA., Johnson BE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Meyerson M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Jeselsohn R; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Qiu X; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Li R; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Long H; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Winer EP; Yale Cancer Center, Yale School of Medicine, Smilow Cancer Hospital, New Haven, CT, USA., Dillon D; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Curigliano G; Division of Early Drug Development, European Institute of Oncology IRCCS, Milano, Italy., Cherniack AD; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Lin NU; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Publikováno v:
Nature communications [Nat Commun] 2023 Nov 18; Vol. 14 (1), pp. 7496. Date of Electronic Publication: 2023 Nov 18.
Autor:
Portnow LH; Brigham and Women's Hospital, Department of Radiology, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Snider LC; Brigham and Women's Hospital, Department of Radiology, Boston, MA, USA., Bolivar KE; Brigham and Women's Hospital, Department of Radiology, Boston, MA, USA., Bychkovsky BL; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA, USA.; Dana-Farber Brigham Cancer Center, Breast Oncology Program, Boston, MA, USA.; Dana-Farber Cancer Institute, Division of Cancer Genetics and Prevention, Boston, MA, USA., Klehm MR; Dana-Farber Cancer Institute, Division of Cancer Genetics and Prevention, Boston, MA, USA., Yeh ED; Brigham and Women's Hospital, Department of Radiology, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Gombos EC; Brigham and Women's Hospital, Department of Radiology, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Chikarmane SA; Brigham and Women's Hospital, Department of Radiology, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Publikováno v:
Journal of breast imaging [J Breast Imaging] 2023 Sep 22; Vol. 5 (5), pp. 508-519.
Autor:
Sorouri K; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Lynce F; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Feltmate CM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA., Davis MR; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA., Muto MG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA., Konstantinopoulos PA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA., Stover EH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA., Kurian AW; Stanford University School of Medicine, Stanford, CA., Hill SJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Garber JE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Bychkovsky BL; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2023 Sep; Vol. 7, pp. e2300290.
Autor:
King CB; Comprehensive Breast Health Center, Brigham and Women's Hospital, Boston, MA, USA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Bychkovsky BL; Comprehensive Breast Health Center, Brigham and Women's Hospital, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Warner ET; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., King TA; Comprehensive Breast Health Center, Brigham and Women's Hospital, Boston, MA, USA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Freedman RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mittendorf EA; Comprehensive Breast Health Center, Brigham and Women's Hospital, Boston, MA, USA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Katlin F; Comprehensive Breast Health Center, Brigham and Women's Hospital, Boston, MA, USA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Revette A; Division of Population Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, USA., Crookes DM; Department of Health Sciences, Northeastern University, Boston, MA, USA.; Department of Sociology and Anthropology, Northeastern University, Boston, MA, USA., Maniar N; Department of Health Sciences, Northeastern University, Boston, MA, USA., Pace LE; Comprehensive Breast Health Center, Brigham and Women's Hospital, Boston, MA, USA. lpace@bwh.harvard.edu.; Harvard Medical School, Boston, MA, USA. lpace@bwh.harvard.edu.; Division of Women's Health, Brigham and Women's Hospital, Boston, MA, USA. lpace@bwh.harvard.edu.
Publikováno v:
BMC primary care [BMC Prim Care] 2023 Aug 25; Vol. 24 (1), pp. 165. Date of Electronic Publication: 2023 Aug 25.